<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01883596</url>
  </required_header>
  <id_info>
    <org_study_id>HPS-02</org_study_id>
    <nct_id>NCT01883596</nct_id>
  </id_info>
  <brief_title>Chlorhexidine Gluconate for Prevention of Ventilator Associated Pneumonia in Children.</brief_title>
  <official_title>Chlorhexidine Gluconate for Prevention of Ventilator Associated Pneumonia in a Pediatric Intensive Care Unit.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Sinaloa Pediatric Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Sinaloa Pediatric Hospital</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      To determine the efficacy of prophylaxis with 0.12% chlorhexidine gluconate compared with
      placebo to prevent ventilator associated pneumonia in children admitted to a pediatric
      critical care unit.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Randomised controlled trial to determine the efficacy of 0.12% chlorhexidine gluconate
      compared with placebo to prevent ventilator associated pneumonia in children admitted to a
      pediatric critical care unit.
    </textblock>
  </detailed_description>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date>October 2012</start_date>
  <completion_date type="Anticipated">December 2016</completion_date>
  <primary_completion_date type="Anticipated">October 2016</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double (Participant, Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Incidence of ventilator associated pneumonia</measure>
    <time_frame>Participants will be followed for the duration of intensive care unit stay, an expected average of 2 weeks</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Mortality</measure>
    <time_frame>Participants will be followed for the duration of intensive care unit stay, an expected average of 2 weeks</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Days of mechanical ventilation</measure>
    <time_frame>From date of randomization until the date of death or date of extubation, whichever comes first, an expected average of 2 weeks</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Length of stay</measure>
    <time_frame>From date of randomization until the date of death or date of discharge from the intensive care unit, an expected average of 2 weeks</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">70</enrollment>
  <condition>Mechanical Ventilation for More Than 48 Hours.</condition>
  <arm_group>
    <arm_group_label>0.12% Chlorhexidine</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Bexident® (0.12% chlorhexidine) solution, applied topically, every 8 hrs.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Placebo</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>7.4% alcohol, glycerine, normal saline solution, applied topically, every 8 hrs.</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>0.12% chlorhexidine solution</intervention_name>
    <description>Bexident® (0.12% chlorhexidine solution)</description>
    <arm_group_label>0.12% Chlorhexidine</arm_group_label>
    <other_name>Peridex, Betasept, PerioGard.</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Placebo</intervention_name>
    <description>7.4% alcohol, glycerine, normal saline solution, applied topically, every 8 hrs.</description>
    <arm_group_label>Placebo</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Children aged 1 month to 18 years admitted to the intensive care unit.

          -  Intubated for more than 48 hours.

        Exclusion Criteria:

          -  Clinical or radiological diagnosis of pneumonia previous to the endotracheal
             intubation.

          -  Allergy to chlorhexidine.

          -  Known immune deficiency.

        Elimination Criteria:

          -  Transfer to another hospital.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>1 Month</minimum_age>
    <maximum_age>18 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Jesus J Martinez, MD</last_name>
    <role>Study Chair</role>
    <affiliation>Sinaloa Pediatric Hospital</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Jesus J Martinez, MD</last_name>
    <phone>+52 (667) 7139004</phone>
    <phone_ext>274</phone_ext>
    <email>jjmtz64@hotmail.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Luz I Zamudio, MD</last_name>
    <phone>+52 (667) 7164686</phone>
    <email>zluz_isabel@hotmail.com</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Sinaloa Pediatric Hospital</name>
      <address>
        <city>Culiacan</city>
        <state>Sinaloa</state>
        <zip>80200</zip>
        <country>Mexico</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jesus J Martinez, MD</last_name>
      <phone>+52 (667) 7139004</phone>
      <phone_ext>274</phone_ext>
      <email>jjmtz64@hotmail.com</email>
    </contact>
    <contact_backup>
      <last_name>Luz I Zamudio, MD</last_name>
      <phone>+52 (667) 7164686</phone>
      <email>zluz_isabel@hotmail.com</email>
    </contact_backup>
    <investigator>
      <last_name>Jesus J Martinez, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Mexico</country>
  </location_countries>
  <verification_date>December 2015</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>June 11, 2013</study_first_submitted>
  <study_first_submitted_qc>June 19, 2013</study_first_submitted_qc>
  <study_first_posted type="Estimate">June 21, 2013</study_first_posted>
  <last_update_submitted>December 7, 2015</last_update_submitted>
  <last_update_submitted_qc>December 7, 2015</last_update_submitted_qc>
  <last_update_posted type="Estimate">December 8, 2015</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Sinaloa Pediatric Hospital</investigator_affiliation>
    <investigator_full_name>Jesús Javier Martínez-García</investigator_full_name>
    <investigator_title>MD</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Pneumonia</mesh_term>
    <mesh_term>Pneumonia, Ventilator-Associated</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Pharmaceutical Solutions</mesh_term>
    <mesh_term>Chlorhexidine</mesh_term>
    <mesh_term>Chlorhexidine gluconate</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

